From bench to bedside: Single-cell analysis for cancer immunotherapy

Emily F Davis-Marcisak1, Atul Deshpande2, Genevieve L Stein-O'Brien1

  • 1McKusick-Nathans Institute of the Department of Genetic Medicine, Johns Hopkins School of Medicine, 550 N Broadway, Suite 1101E, Baltimore, MD 21205, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Room 485, Baltimore, MD 21287, USA; Convergence Institute, Johns Hopkins University, Baltimore, MD, USA; Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cancer Cell
|July 30, 2021
PubMed
Summary

Single-cell technologies offer powerful insights into cancer's complexity and therapeutic responses. This review covers essential sample processing and computational analysis for advancing cancer immunotherapy research.

Related Concept Videos